A new healthcare investment fund, HealthKois, has been launched with a target corpus of $300 million and an additional green shoe option of $100 million. The fund has been set up by the founding team of HealthQuad—Charles Janssen, Ajay Mahipal, and Dr Pinak Shrikhande—and is positioned as a successor to the earlier HealthQuad funds. HealthKois plans to invest between $7 million and $25 million in early growth-stage companies across sectors such as HealthTech, MedTech, Life Sciences, Healthcare Delivery, and Climate Health. The fund will focus on companies with scalable business models, clinical outcome potential, and infrastructure-oriented solutions. According to the team, HealthKois will adopt a hands-on investment approach, providing strategic support in addition to capital, including guidance on go-to-market strategies, organisational development, and governance. The fund will also align with international sustainability standards, including the UN Sustainable Development Goal #3 and Article 9 of the EU Sustainable Finance Disclosure Regulation. “Our aim is to work with healthcare ventures that address systemic challenges in access, affordability, and quality,” said Charles Janssen, Managing Partner at HealthKois. Ajay Mahipal, Partner at HealthKois, noted that the fund will engage closely with founders to support long-term growth, particularly in India and other low- and middle-income markets. Dr Pinak Shrikhande added that the fund will prioritise companies capable of delivering tangible clinical and operational outcomes, and that HealthKois will bring sector-specific expertise to support execution. HealthKois follows the trajectory of HealthQuad Funds I and II, which have previously invested in companies reportedly reaching over 90 million lives and serving 8.2 million patients annually. While those funds will continue under existing mandates, HealthKois will operate as an independent platform focused on the next phase of healthcare investment. (Edited by Megha Reddy)